There are some skin conditions we're very familiar with: spots during adolescence, allergic rashes, sunburn. But others are ...

Investigators sought to better understand how race and ethnicity was related to the severity of rosacea phenotypes among adults.

telangiectasia, inflammatory lesions, and ocular manifestations. Among the more recently approved treatments for rosacea — and among products and drug indications under study — “notice there ...

and spider veins (telangiectasia). According to The National Rosacea Society it is estimated that rosacea affects over 16 million Americans and as many as 415 million people worldwide.

The medication can be taken with or without food, though ingestion of food along with Emrosi may help reduce the risk of esophageal irritation and ulceration. Emrosi ™ (minocycline hydrochloride ...

Encelto is the first FDA-approved treatment for macular telangiectasia type 2. The cell therapy slows the loss of macular photoreceptors through continuous delivery of ciliary neurotrophic factor.

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

While in high school, I finally took the initiative to find answers for my condition, and that's when my dermatologist told me about rosacea. Rosacea is a chronic skin condition characterized by ...

for the treatment of Macular Telangiectasia type 2 (MacTel). MacTel is a neurodegenerative disease of the retina in adults that causes progressive and irreversible vision loss, significantly ...

U.S. FDA approved Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the treatment of inflammatory lesions of rosacea in adults ...